Efficacy and Safety of Grazoprevir (MK-5172) and Uprifosbuvir (MK-3682) With Elbasvir (MK-8742) or Ruzasvir (MK-8408) for Chronic Hepatitis C Genotype (GT)1 and GT2 Infection (MK-3682-011)
Clinical trial NCT02332707 · COMPLETED
Trial details
- NCT number
- NCT02332707
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-01-22
- Primary completion
- 2016-09-16
- Enrollment
- 443
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.